AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 109 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $249,760 | -35.9% | 6,244 | -29.6% | 0.00% | 0.0% |
Q1 2024 | $389,350 | -41.7% | 8,867 | -17.8% | 0.00% | -66.7% |
Q4 2023 | $667,485 | +53.8% | 10,792 | +14.4% | 0.00% | +50.0% |
Q3 2023 | $433,962 | -3.9% | 9,436 | +20.1% | 0.00% | 0.0% |
Q2 2023 | $451,369 | +76.9% | 7,854 | +15.4% | 0.00% | +100.0% |
Q1 2023 | $255,113 | +16.3% | 6,803 | -13.1% | 0.00% | 0.0% |
Q4 2022 | $219,425 | +20.6% | 7,831 | +21.2% | 0.00% | 0.0% |
Q3 2022 | $182,000 | -19.1% | 6,462 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $225,000 | +16.0% | 6,462 | +19.6% | 0.00% | 0.0% |
Q1 2022 | $194,000 | +24.4% | 5,401 | -19.5% | 0.00% | 0.0% |
Q4 2021 | $156,000 | +132.8% | 6,710 | +89.1% | 0.00% | – |
Q3 2021 | $67,000 | -6.9% | 3,549 | 0.0% | 0.00% | – |
Q2 2021 | $72,000 | -26.5% | 3,549 | -33.5% | 0.00% | -100.0% |
Q1 2021 | $98,000 | -8.4% | 5,340 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $107,000 | +7.0% | 5,340 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $100,000 | -16.7% | 5,340 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $120,000 | +233.3% | 5,340 | +121.5% | 0.00% | – |
Q1 2020 | $36,000 | -23.4% | 2,411 | 0.0% | 0.00% | – |
Q4 2019 | $47,000 | -2.1% | 2,411 | 0.0% | 0.00% | – |
Q3 2019 | $48,000 | -5.9% | 2,411 | 0.0% | 0.00% | – |
Q2 2019 | $51,000 | +4.1% | 2,411 | 0.0% | 0.00% | – |
Q1 2019 | $49,000 | -22.2% | 2,411 | -24.4% | 0.00% | -100.0% |
Q4 2018 | $63,000 | +3.3% | 3,188 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $61,000 | +24.5% | 3,188 | 0.0% | 0.00% | – |
Q2 2018 | $49,000 | -18.3% | 3,188 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $60,000 | -1.6% | 3,188 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $61,000 | +64.9% | 3,188 | +53.0% | 0.00% | – |
Q3 2017 | $37,000 | 0.0% | 2,083 | 0.0% | 0.00% | – |
Q2 2017 | $37,000 | +23.3% | 2,083 | 0.0% | 0.00% | – |
Q1 2017 | $30,000 | -21.1% | 2,083 | 0.0% | 0.00% | – |
Q4 2016 | $38,000 | -5.0% | 2,083 | 0.0% | 0.00% | – |
Q3 2016 | $40,000 | +42.9% | 2,083 | +19.2% | 0.00% | – |
Q2 2016 | $28,000 | +33.3% | 1,748 | 0.0% | 0.00% | – |
Q1 2016 | $21,000 | -16.0% | 1,748 | 0.0% | 0.00% | – |
Q4 2015 | $25,000 | +316.7% | 1,748 | +268.8% | 0.00% | – |
Q3 2015 | $6,000 | – | 474 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Summit Global Investments | 58,640 | $870,000 | 0.13% |
FEDERATED HERMES, INC. | 2,600,120 | $38,586,000 | 0.11% |
ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 284,328 | $4,219,000 | 0.07% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 291,352 | $4,324,000 | 0.05% |
MARSHALL WACE, LLP | 301,910 | $4,481,000 | 0.04% |
MARTINGALE ASSET MANAGEMENT L P | 212,817 | $3,159,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 171,266 | $2,542,000 | 0.03% |
WINTON GROUP Ltd | 82,402 | $1,223,000 | 0.03% |
EAGLE ASSET MANAGEMENT INC | 317,988 | $4,718,000 | 0.03% |
Engineers Gate Manager LP | 24,007 | $356,000 | 0.03% |